Home/Recalls/CANADA-77402
Health CanadaType I

JAMP-Pregabalin: One lot recalled as some bottles may contain 150 mg capsules

Published: May 5, 2025Recall ID: 77402Category: generalCountry: Canada

Reason for Recall / Hazard

Product safety

Product Description & Identification

Check your medication bottle to ensure it only contains 50 mg capsules.The 50 mg capsule is white with “PG” and “50” printed on it in black ink.The 150 mg capsule is white with “PG” and “150” printed on it in black ink.If it contains any 150 mg capsules, or if you are unsure, return it to your pharmacy immediately. Your pharmacist will check the capsules and provide you with a replacement, if needed.If you are unable to return your capsules to the pharmacy right away, talk to your pharmacist or doctor for further guidance.Seek immediate medical attention if you are experiencing symptoms of an overdose (e.g., confusion, agitation, restlessness and seizures).Do not stop taking pregabalin without first speaking to your doctor, as stopping abruptly may result in withdrawal symptoms.If you have questions about this recall, contact JAMP Pharma Corp. by calling 1-866-399-9091, extension 501, or by emailing custjamp@jamppharma.com.Report any health product-related side effects or complaints to Health Canada.

Affected Products

JAMP-Pregabalin

Additional Source Details

FieldValue
N I D77402
U R Lhttps://recalls-rappels.canada.ca/en/alert-recall/jamp-pregabalin-one-lot-recalled-some-bottles-may-contain-150-mg-capsules
IssueProduct safety
TitleJAMP-Pregabalin: One lot recalled as some bottles may contain 150 mg capsules
ProductJAMP-Pregabalin
Archived0
CategoryDrugs
Last updated2025-05-05
OrganizationDrugs and health products
Recall classType I
What you should doCheck your medication bottle to ensure it only contains 50 mg capsules.The 50 mg capsule is white with “PG” and “50” printed on it in black ink.The 150 mg capsule is white with “PG” and “150” printed on it in black ink.If it contains any 150 mg capsules, or if you are unsure, return it to your pharmacy immediately. Your pharmacist will check the capsules and provide you with a replacement, if needed.If you are unable to return your capsules to the pharmacy right away, talk to your pharmacist or doctor for further guidance.Seek immediate medical attention if you are experiencing symptoms of an overdose (e.g., confusion, agitation, restlessness and seizures).Do not stop taking pregabalin without first speaking to your doctor, as stopping abruptly may result in withdrawal symptoms.If you have questions about this recall, contact JAMP Pharma Corp. by calling 1-866-399-9091, extension 501, or by emailing custjamp@jamppharma.com.Report any health product-related side effects or complaints to Health Canada.

Overview

  • Recalling FirmDrugs and health products
  • Risk LevelType I
Official Agency Alert